NASDAQ:KYTX | Cash Flow Statement | Kyverna Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2023-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$38.32M
2026-03-31-$39.73M$351,000.00-$41.6M-$50.2M-$101,000.00
2025-12-31-$37.8M$368,000.00-$33.53M-$1,000.00-$17.29M$140.74M
2025-09-30-$36.79M
2025-06-30-$42.08M
2025-03-31-$44.64M$501,000.00-$44.92M$0.00$5.58M-$414,000.00
2024-12-31-$37.49M$563,000.00-$37.06M$532,000.00$29.22M-$215,000.00
2024-09-30-$34.49M
2024-06-30-$28.8M
2024-03-31-$26.69M$482,000.00-$25.53M$543,000.00-$122.88M$338.05M
2023-12-31-$20.67M$462,000.00-$18.56M$334,000.00$31.68M-$1.43M
2023-09-30-$15.47M
2023-06-30-$13.09M
2023-03-31-$11.14M$394,000.00-$11.46M$28,000.00$13.66M-$144,000.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$161.31M$1.8M-$153.71M$5,000.00$40.02M$141.17M
2024-12-31-$127.48M$2.13M-$114.25M$2.21M-$160.9M$337.11M
2023-12-31-$60.37M$1.71M-$52.41M$621,000.00-$8.79M$58.12M